Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Živa Pohar-Marinšek) .

1 - 10 / 16
First pagePrevious page12Next pageLast page
1.
Evolving strategies in the treatment of childhood rhabdomyosarcoma : Slovenian experience
Živa Pohar-Marinšek, Jožica Anžič, Berta Jereb, 2001, original scientific article

Abstract: Background. Neoadjuvant chemotherapy (Cht) has changed the treatment of rhabdomyosarcoma (RMS) in children. The purpose of our study was to review thechildren treated for RMS between 1974 and 1996. Patients and methods. Fifty-one children, 1-15 years old, were included. Primary sites of tumour were: head and neck 15, orbit 6, genitourinary 12, extremity 9, torso 5 and paratesticular 4. Twelve patients were in stage 1, 10 in stage II, 26 in stage111 and 3 in stage IV. Of 43 histologically confirmed RMS 25 were embryonal, 13 alveolar, 1 botryoid, 1 spindle cell and 3 sarcoma NOS. In 8 patients, only fine needle aspiration biopsy (FNAB) was available. All patients had Cht, 29 neoadjuvant, 20 had surgery first, 40 had irradiation (RT), 2 stage IV patients had bone marrow transplant (ABMT). Multidrug Cht varied: VCR, AMD, and cyclophosphamide (VAC) were used in the 1970s, with Adriablastine (T2), methotrexat (MTX) and/or other drugs (T6, T11) in the 1980s; and in the 1990s, cyclophosphamide was replaced by ifosfamide (VAIA). The treatment was started with Cht in orbital and head and neck tumours and inthe majority of genitourinary tumours, but surgery was first in paratesticular and in the majority of extremity tumours. Results. The 3 patients with stage IV disease died. Of those with localised tumour, 34 (70%) were alive and well 5 years after treatment, 80% stage I, 75% stage II and 61%stage III. One patient died of heart failure, 3 of Cht toxicity and 1 of intereurrent disease. Conclusions. (Abstract truncated at 2000 characters)
Published in DiRROS: 26.01.2024; Views: 79; Downloads: 19
.pdf Full text (177,30 KB)

2.
3.
4.
Navodila za poenotenje izvidov brisov materničnega vratu
Ana Pogačnik, Irena Srebotnik-Kirbiš, Alenka Repše-Fokter, Živa Pohar-Marinšek, Vivijana Snoj, Irena Kirar-Fazarinc, Maja Primic-Žakelj, 2005, dictionary, encyclopaedia, lexicon, manual, atlas, map

Keywords: bris, citopatologija
Published in DiRROS: 04.06.2020; Views: 1713; Downloads: 499
.pdf Full text (1,15 MB)

5.
6.
Citopatološka diagnostika raka dojk
Živa Pohar-Marinšek, 2016, published professional conference contribution

Keywords: citopatologija, rak dojke, diagnostične metode
Published in DiRROS: 20.05.2020; Views: 1554; Downloads: 472
.pdf Full text (48,44 KB)

7.
8.
Prve izkušnje s triažnim testom HPV v Sloveniji
Urška Ivanuš, Mario Poljak, Živa Pohar-Marinšek, Marjetka Uršič-Vrščaj, 2011, published professional conference contribution

Published in DiRROS: 07.04.2020; Views: 1611; Downloads: 436
.pdf Full text (186,58 KB)

9.
Aspiracijska biopsija v diagnostiki tumorjev mehkih tkiv
Živa Pohar-Marinšek, 1992, published scientific conference contribution

Keywords: onkologija, rak (medicina), tumor, mehka tkiva, diagnostika
Published in DiRROS: 16.09.2019; Views: 1994; Downloads: 520
.pdf Full text (400,24 KB)

10.
Search done in 0.36 sec.
Back to top